EA200900593A1 - Производные птеридина как ингибиторы polo-подобной киназы, применяющиеся при лечении рака - Google Patents
Производные птеридина как ингибиторы polo-подобной киназы, применяющиеся при лечении ракаInfo
- Publication number
- EA200900593A1 EA200900593A1 EA200900593A EA200900593A EA200900593A1 EA 200900593 A1 EA200900593 A1 EA 200900593A1 EA 200900593 A EA200900593 A EA 200900593A EA 200900593 A EA200900593 A EA 200900593A EA 200900593 A1 EA200900593 A1 EA 200900593A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- derivatives
- optionally substituted
- ring
- polo
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Соединения формулы (I) являются ингибиторами Polo-подобных киназ (PLKs) и применяются в лечении клеточно-пролиферативных заболеваний, где Rи Rявляется водородом или факультативно замещенной (С-С)алкильной, (С-С)алкенильной, (С-С)алкинильной или (С-С)циклоалкильной группой; Rи R' являются независимо друг от друга выбранными из водорода, -CN, гидроксила, галогена, факультативно замещенного (С-С)алкила, (С-С)алкенила, (С-С)алкинила или (С-С)циклоалкила, -NRRили (С-С)алкокси, где Rи Rявляются независимо друг от друга водородом или факультативно замещенным (С-С)алкилом; кольцо А является факультативно замещенным моно- или бициклическим карбоциклическим или гетероциклическим кольцом или кольцевой системой, имеющей до 12 атомов в кольце; Т является радикалом формулы R-L-Y, где R является альфа-аминокислотой или мотивом эфира альфа-аминокислоты, связанным с кольцом А линкером R-LY, как определено в формуле.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0621205A GB0621205D0 (en) | 2006-10-25 | 2006-10-25 | Inhibitors of PLK |
GB0715614A GB0715614D0 (en) | 2007-08-10 | 2007-08-10 | Inhibitors of plk |
PCT/GB2007/003998 WO2008050096A1 (en) | 2006-10-25 | 2007-10-19 | Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200900593A1 true EA200900593A1 (ru) | 2010-06-30 |
Family
ID=38896021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200900593A EA200900593A1 (ru) | 2006-10-25 | 2007-10-19 | Производные птеридина как ингибиторы polo-подобной киназы, применяющиеся при лечении рака |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100216802A1 (ru) |
EP (1) | EP2079743B1 (ru) |
JP (1) | JP2010507639A (ru) |
KR (1) | KR20090071668A (ru) |
AT (1) | ATE542820T1 (ru) |
AU (1) | AU2007310604B2 (ru) |
BR (1) | BRPI0718120A2 (ru) |
CA (1) | CA2665736A1 (ru) |
EA (1) | EA200900593A1 (ru) |
IL (1) | IL198082A0 (ru) |
MX (1) | MX2009004244A (ru) |
NZ (1) | NZ577153A (ru) |
WO (1) | WO2008050096A1 (ru) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0619753D0 (en) | 2006-10-06 | 2006-11-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
CA2668070A1 (en) * | 2006-10-30 | 2008-05-08 | Chroma Therapeutics Ltd. | Hydroxamates as inhibitors of histone deacetylase |
MX2009006345A (es) | 2006-12-14 | 2009-06-23 | Vertex Pharma | Compuestos utiles como inhibidores de proteina cinasa. |
GB0803747D0 (en) | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
GB0807451D0 (en) * | 2008-04-24 | 2008-05-28 | Chroma Therapeutics Ltd | Inhibitors of PLK |
CA2728729C (en) | 2008-06-23 | 2016-09-27 | Vertex Pharmaceuticals Incorporated | Protein kinase inhibitors |
WO2010008459A1 (en) * | 2008-06-23 | 2010-01-21 | Vertex Pharmaceuticals Incorporated | Protein kinase inhibitors |
GB0903480D0 (en) | 2009-02-27 | 2009-04-08 | Chroma Therapeutics Ltd | Enzyme Inhibitors |
EP2473488A4 (en) * | 2009-09-04 | 2013-07-17 | Zalicus Pharmaceuticals Ltd | SUBSTITUTED HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF PAIN AND EPILEPSY |
CN102020643A (zh) * | 2009-09-22 | 2011-04-20 | 上海恒瑞医药有限公司 | 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用 |
GB201211310D0 (en) | 2012-06-26 | 2012-08-08 | Chroma Therapeutics Ltd | CSF-1R kinase inhibitors |
RU2676329C2 (ru) | 2012-10-17 | 2018-12-28 | Макрофейдж Фарма Лимитед | Трет-бутил-n-[2-{ 4-[6-амино-5-(2,4-дифторбензоил)-2-оксопиридин-1(2н)-ил]-3,5-дифторфенил} этил]-l-аланинат или его соль, гидрат или сольват |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
WO2015116696A1 (en) | 2014-01-28 | 2015-08-06 | Massachusetts Institute Of Technology | Combination therapies and methods of use thereof for treating cancer |
JP2017504653A (ja) | 2014-01-31 | 2017-02-09 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | ジアミノピリミジンベンゼンスルホン誘導体およびその使用 |
JP2017512186A (ja) * | 2014-01-31 | 2017-05-18 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | ジヒドロプテリジノン誘導体およびその使用 |
JP2017504651A (ja) | 2014-01-31 | 2017-02-09 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | ジアゼパン誘導体の使用 |
RU2750164C2 (ru) | 2015-09-11 | 2021-06-22 | Дана-Фарбер Кэнсер Инститьют, Инк. | Цианотиенотриазолодиазепины и пути их применения |
WO2017091673A2 (en) | 2015-11-25 | 2017-06-01 | Dana-Farber Cancer Institute, Inc. | Bivalent bromodomain inhibtors and uses thereof |
GB201713975D0 (en) | 2017-08-31 | 2017-10-18 | Macrophage Pharma Ltd | Medical use |
WO2020033823A1 (en) * | 2018-08-10 | 2020-02-13 | Yale University | Small-molecule pi5p4k alpha/beta inhibitors and methods of treatment using same |
CN111039944B (zh) * | 2018-10-12 | 2021-11-23 | 中国科学院合肥物质科学研究院 | Mst1激酶抑制剂及其用途 |
KR102260995B1 (ko) * | 2018-11-28 | 2021-06-04 | 국립암센터 | Plk1의 활성 억제제를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물 |
CN115947728B (zh) * | 2021-10-09 | 2024-01-09 | 沈阳药科大学 | 含磺酰基的二氢喋啶酮衍生物及其应用 |
WO2023158514A1 (en) | 2022-02-18 | 2023-08-24 | Massachusetts Institute Of Technology | Cancer treatment by combined inhibition of polo-like kinase and microtubule polymerization |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1632493A1 (de) * | 2004-08-25 | 2006-03-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
JP2008510770A (ja) * | 2004-08-26 | 2008-04-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Plk阻害剤としての新規プテリジノン |
CA2578560A1 (en) * | 2004-08-27 | 2006-03-02 | Boehringer Ingelheim International Gmbh | Dihydropteridinones, method for the production thereof, and use thereof as a medicament |
-
2007
- 2007-10-19 JP JP2009533934A patent/JP2010507639A/ja not_active Withdrawn
- 2007-10-19 KR KR1020097010620A patent/KR20090071668A/ko not_active Application Discontinuation
- 2007-10-19 US US12/446,008 patent/US20100216802A1/en not_active Abandoned
- 2007-10-19 EA EA200900593A patent/EA200900593A1/ru unknown
- 2007-10-19 MX MX2009004244A patent/MX2009004244A/es not_active Application Discontinuation
- 2007-10-19 BR BRPI0718120-5A patent/BRPI0718120A2/pt not_active IP Right Cessation
- 2007-10-19 WO PCT/GB2007/003998 patent/WO2008050096A1/en active Application Filing
- 2007-10-19 AU AU2007310604A patent/AU2007310604B2/en not_active Ceased
- 2007-10-19 AT AT07824247T patent/ATE542820T1/de active
- 2007-10-19 CA CA002665736A patent/CA2665736A1/en not_active Abandoned
- 2007-10-19 NZ NZ577153A patent/NZ577153A/en not_active IP Right Cessation
- 2007-10-19 EP EP07824247A patent/EP2079743B1/en not_active Not-in-force
-
2009
- 2009-04-07 IL IL198082A patent/IL198082A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2009004244A (es) | 2009-05-14 |
US20100216802A1 (en) | 2010-08-26 |
CA2665736A1 (en) | 2008-05-02 |
BRPI0718120A2 (pt) | 2013-11-12 |
KR20090071668A (ko) | 2009-07-01 |
JP2010507639A (ja) | 2010-03-11 |
AU2007310604A1 (en) | 2008-05-02 |
AU2007310604B2 (en) | 2012-02-02 |
ATE542820T1 (de) | 2012-02-15 |
EP2079743A1 (en) | 2009-07-22 |
IL198082A0 (en) | 2009-12-24 |
NZ577153A (en) | 2012-02-24 |
EP2079743B1 (en) | 2012-01-25 |
WO2008050096A1 (en) | 2008-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200900593A1 (ru) | Производные птеридина как ингибиторы polo-подобной киназы, применяющиеся при лечении рака | |
ES2509820T3 (es) | Derivados de indazol como inhibidores de la cinasa para el tratamiento del cáncer | |
PE20220931A1 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
ES2524966T3 (es) | Derivados de tieno[3,2-c]piridina como inhibidores de quinasas para uso en el tratamiento del cáncer | |
MX2012002059A (es) | Compestos heterociclicos triciclicos como inhibidores de fosfoionositida 3-quinasa. | |
BR0316146A (pt) | Derivados de amida do ácido 3-(2-hidróxifenil)-1h-pirazol-4-carboxìlico como inibidores de hsp90 para o tratamento de câncer | |
TW200740805A (en) | Novel compounds | |
AR067599A1 (es) | Derivados de indazol sustituido activos como inhibidores de quinasa | |
CO6321276A2 (es) | Derivados de tiazol usados como inhibidores de pi3- cinasa | |
PE20151981A1 (es) | Pontenciador de inhibidores del homologo de zeste | |
MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
PE20120058A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
NO20061157L (no) | 4-pyramidonderivater og deres anvendelse som peptidylpeptidmeinbibitorer | |
MY148566A (en) | Crystalline solvates and complexes of (is) -1, 5- anhydro-1 -c-(3-( (phenyl) methyl) phenyl) -d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes | |
WO2006123165A3 (en) | Pyrimidine derivatives as hsp90 inhibitors | |
GEP20156267B (en) | 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES | |
AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
PE20110213A1 (es) | Derivados de indolinona como inhibidores de quinasa | |
EA201101566A1 (ru) | Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ | |
PE20090216A1 (es) | Compuestos triazolil aminopirimidina | |
MX2010000658A (es) | Derivados de pirimidina 934. | |
NZ592429A (en) | PHENANTHROINDOLIZIDINE DERIVATIVE AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT | |
PH12018502411A1 (en) | Novel 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one derivative | |
MX2019008331A (es) | Derivados de amino-imidazopiridina novedosos como inhibidores de cinasa de janus y uso farmacéutico de estos. | |
WO2008110690A3 (fr) | Nouveaux derives indoliques, leurs procedes de preparation et leurs utilisations notamment en tant qu'antibacteriens |